CCK-8, wound-healing and Transwell assays were used to detect cancer cell proliferation and migration. Transcriptome sequencing was applied to screen downstream target genes regulated by cordycepin.
Key Findings:
Cordycepin at proper doses significantly blocks cell cycle progression and inhibits in vitro proliferation of lung cancer cells.
Cordycepin downregulates the expression of key epithelial-mesenchymal transition genes and weakens the invasion and migration capacity of tumor cells.
Cordycepin has potential medicinal development value for anti-lung cancer therapy.